Not surprisingly it was standing room only in the grand ballroom of the Westin St. Francis Hotel in San Francisco for the Roche presentation this morning at the JPMorgan Healthcare Conference .
You'd expect high interest after the "Financial Times" reported last Friday afternoon that the Swiss drugmaker is going to up its bid for Genentech.
Roche CFO Erich Hunziker didn't talk about that. But he did say, "We see very clearly that we will not touch innovation (at Genentech), but there's a lot of synergies we can win in this market."
He acknowledged the "fear" that Roche will "destroy" Genentech , especially here in the Bay Area where DNA is headquartered, but Hunziker said, "The cuts we will do at the Roche side are much tougher that what we will do at the Genentech side."